Investors should keep tabs on these "focus events" from this quartet of U.S.-listed Japanese drugmakers that can make or break their treatments.
Save for a refusing to budge on climate change, U.S. President Donald Trump left the G-20 in Osaka with something a bit unusual for him: some good news.
When it comes to his oft-stated goal of reducing the U.S. trade deficit, President Donald Trump isn't winning. The current account deficit - a broad measure of the trade balance that also encompasses some investment flows - has averaged $48.9 billion a month so far in 2019, roughly 17% higher than in 2016, the last full year before Trump took office.
So, what should investors do after President Trump and President Xi meet at the G20 summit in Japan this weekend? Here's what this NYSE trader thinks.
When loud-mouth politicians stay out of the markets, it is just entertainment, but there's nothing funny about trade wars and Middle East conflict.
Be careful before you start planning your trades based on the Trump-Xi meeting. Here's what Jonathan Corpina, senior managing partner at Meridian Equity Partners, weighs in on what investors should do ahead of the meeting.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.